Veradigm Inc. (MDRX)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Provider	473.07M	492.09M	465.93M	-	-
Payer	67.31M	72.28M	56.21M	-	-
Life Science	54.04M	61.61M	65.88M	-	-
Legacy Veradigm	-	-	-	548.69M	525.18M
Unallocated Amounts	-	-	-	28.74M	30.93M
Total	594.41M	625.98M	588.02M	577.43M	556.12M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
United States	593.71M	625.37M	587.35M	577.43M	556.12M
ALL Other Countries	699.00K	618.00K	666.00K	-	-
Total	594.41M	625.98M	588.02M	577.43M	556.12M

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2022

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 2, 2026

Data Sources Report a data error